Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Effects of Cytogenetic Risk on Outcomes in Multiple Myeloma Treated with Selinexor, Bortezomib, and Dexamethasone (XVd)
Nizar J. Bahlis, Shambavi Richard, Darrell White, Sebastian Grosicki, Christine Chen, Sosana Delimpasi, Heather J. Sutherland, Zvenyslava Maslyak, Michaël Sébag, Maria Gavriatopoulou, Suzanne Lentzsch, Ajai Chari, Maryana Simonova, Ivan Špıčka, Iryna Kriachok, Meletios A Dimopoulos, Halyna Pylypenko, Holger W. Auner, Xavier Leleu, Ganna Usenko, Roman Hájek, Reuben Benjamin, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P. Venner, Mamta Garg, Don A. Stevens, Hang Quach, Sundar Jagannath, Philippe Moreau, Moshe Levy, Ashraf Badros, Larry D. Anderson, Thierry Façon, María‐Victoria Mateos, Michèle Cavo, Andrew DeCastro, Yi Chai, Dane R. Van Domelen, Moran Mishal, Ohad S. Bentur, Jatin J. Shah, Sharon Shacham, Michael Kauffman, Paul G. Richardson (2021). Effects of Cytogenetic Risk on Outcomes in Multiple Myeloma Treated with Selinexor, Bortezomib, and Dexamethasone (XVd). , 138(Supplement 1), DOI: https://doi.org/10.1182/blood-2021-146324.
Article34 days agoIntegrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials
Maria Gavriatopoulou, Ajai Chari, Christine Chen, Nizar J. Bahlis, Dan T. Vogl, Andrzej Jakubowiak, David Dingli, Robert F. Cornell, Craig C. Hofmeister, David S. Siegel, Jesús G. Berdeja, Donna Reece, Darrell White, Suzanne Lentzsch, Cristina Gasparetto, Carol Ann Huff, Sundar Jagannath, Rachid Baz, Ajay K. Nooka, Joshua Richter, Rafat Abonour, Terri L. Parker, Andrew J. Yee, Philippe Moreau, Sagar Lonial, Sascha A. Tuchman, Katja Weisel, Mohamad Mohty, Sylvain Choquet, Thaddeus J. Unger, Kwok Yan Li, Yi Chai, Lingling Li, Jatin J. Shah, Sharon Shacham, Michael Kauffman, Meletios A Dimopoulos (2020). Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials. , 34(9), DOI: https://doi.org/10.1038/s41375-020-0756-6.
Article34 days agoLenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma
Lotfi Benboubker, Meletios A Dimopoulos, Angela Dispenzieri, John Catalano, Andrew R. Belch, Michèle Cavo, Antonio Pinto, Katja Weisel, Heinz Ludwig, Nizar J. Bahlis, Anne Banos, Mourad Tiab, Michel Delforge, Jamie Cavenagh, Catarina Geraldes, Je‐Jung Lee, Christine Chen, Albert Oriol, Javier de la Rubia, Lugui Qiu, Darrell White, Daniel Binder, Kenneth Anderson, Jean-Paul Fermand, Philippe Moreau, Michel Attal, Robert Knight, Guang Chen, Jason Van Oostendorp, Christian Jacques, Annette Ervin‐Haynes, Hervé Avet‐Loiseau, Cyrille Hulin, Thierry Façon (2014). Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma. , 371(10), DOI: https://doi.org/10.1056/nejmoa1402551.
Article34 days agoPomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
Jesús F. San Miguel, Katja Weisel, Philippe Moreau, Martha Q. Lacy, Kevin Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Anne Banos, Albert Oriol, Adrían Alegre, Christine Chen, Michèle Cavo, Laurent Garderet, Valentina Ivanova, Joaquín Martínez‐López, Andrew R. Belch, Antonio Palumbo, Stephen Schey, Pieter Sonneveld, Xin Yu, Lars Sternås, Christian Jacques, Mohamed H. Zaki, Meletios A Dimopoulos (2013). Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial. , 14(11), DOI: https://doi.org/10.1016/s1470-2045(13)70380-2.
Article34 days agoProlonged Overall Survival with Lenalidomide Plus Dexamethasone Compared with Dexamethasone Alone in Patients with Relapsed or Refractory Multiple Myeloma.
Donna Weber, Robert Knight, Christine Chen, Andrew Spencer, Zhinuan Yu, Jerome B. Zeldis, Marta Olesnyckyj, Meletios A Dimopoulos (2007). Prolonged Overall Survival with Lenalidomide Plus Dexamethasone Compared with Dexamethasone Alone in Patients with Relapsed or Refractory Multiple Myeloma.. , 110(11), DOI: https://doi.org/10.1182/blood.v110.11.412.412.
Article34 days ago